Science News

... from universities, journals, and other research organizations

New Breakthrough in Fight Against Lethal CCHF Virus

May 21, 2010 — Crimean-Congo haemorrhagic fever (CCHF) virus is a rare but serious human infection that causes internal bleeding, organ failure and ultimately death. Scientists writing in the Journal of General Virology have developed a new model to study CCHF which should enhance the development of vaccines and antivirals against this deadly disease.


Share This:

CCHF virus is a tick-borne pathogen that infects (but does not cause disease in) wild and domestic animals in many countries in Africa, Europe and Asia. Humans may become infected from a tick bite or through direct contact with blood or other infected tissues from livestock such as cattle, sheep and goats. CCHF infections in humans lead to serious disease and have a fatality rate of approximately 30%. New vaccines and treatments are urgently needed to combat the CCHF virus, but their development is being hindered by a lack of suitable animal models for testing.

Scientists from the Swedish Institute for Infectious Disease Control, Solna, Sweden have now found that immune-deficient mice can be used as a model to study how CCHF virus behaves in humans. The group discovered that mice unresponsive to key antiviral molecules produced by their innate immune system developed classic symptoms of CCHF viral infection that were fatal.

Dr Ali Mirazimi who led the study, believes the groups' work will contribute enormously to vaccine and antiviral development studies. "To date there is no safe or effective vaccine available for human use or a specific antiviral for CCHF virus," he said. "A reliable animal model is the only way that the safety and effectiveness of a potential vaccine or antiviral treatment can be properly evaluated," he explained.

New strategies to control the spread of the CCHF virus could also have huge economic impact for farmers in developing countries. "As the virus can be transmitted to humans via infected animal tissues, farmers who breed food-producing animals can lose huge amounts of money if their stocks have to be culled," explained Dr Mirazimi.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Society for General Microbiology, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. S. Bereczky, G. Lindegren, H. Karlberg, S. Akerstrom, J. Klingstrom, A. Mirazimi. Crimean Congo haemorrhagic fever virus infection is lethal for adult 1 type I interferon receptor knock-out mice. Journal of General Virology, 2010; DOI: 10.1099/vir.0.019034-0
APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 138,557

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
Interested in ad-free access? If you'd like to read ScienceDaily without ads, let us know!
  more breaking science news

Social Networks


Follow ScienceDaily on Facebook, Twitter,
and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

  • more science news

In Other News ...

  • more top news

Science Video News


Cleaning Infected Blood

Infectious disease experts designed a machine called the hemopurifier. It works much like a dialysis machine, using thin fibers to capture and remove. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: